Results of a comparative study of biokinetics of two prodrugs gidazepam (I)
and the derivative of peptideaminobenzophenone, 2-N-carbobenzylglycy1-glyc
ylamido-5 -bromobenzophenone (II) and their main physiologically active met
abolite - 7-brom-5-phenyl-dihydro-3H-1,4-benzodiaze pine (III) were investi
gated in mice. It was shown earlier that I undergoes intensive N(1_)desalky
lation with the formation of a metabolite: (III) and products of its furthe
r oxidation. Metabolism of II is characterized by hydrolysis of the peptide
fragment and subsequent intramolecular condensation resulting in the forma
tion of III, its oxi- and metoxylated derivatives and other minor metabolit
es. The difference between kinetics of C-14-contents in organs and tissues
of mice following administration of prodrugs I, II and their metabolite III
are demonstrated: In the first two cases no rapid distribution phase of I
and II was detected; maximal levels of III were achieved faster (0.25-0.35
min) and its elimination proceeded with higher rates. For all substances th
e organs and tissues studied are not "stores" of slow exchange of C-14_ mat
erial between serum and brain and are essentially different. After administ
ration of I and I[I, the relationship between C-14-contents in brain and se
rum change demonstrating a loop over the whole period of the experiment whi
ch allows to suggest that serum acts as the central compartment, whereas br
ain is a peripheral comparament of a kinetic scheme of distribution of prod
rugs in mice.Following administration of III, we observed a linear relation
ship between serum and brain C-14-contents which did not depend on the expe
rimental time.
This finding suggests that the, studied biosubstrates act as one (central)
compartment of a kinetic scheme of distribution of III. It is demonstrated
that the peculiarities of their pharmacologic action of prodrugs are explai
ned by the non-linearity of the processes of their biotransformation and sp
ecific of biokinetics.